ARCTURUS THERAPEUTICS HOLDINGS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $161.94M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $186.58M, a 776.86% increase year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $75.31M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $0.00.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for fiscal 2025 was $11.69M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for fiscal 2020 was $423.82M, a 1891.82% increase from fiscal 2019.
- ARCTURUS THERAPEUTICS HOLDINGS INC. stock issued during period, value, new issues for fiscal 2019 was $21.28M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $11.69M 10-K · filed 2026-03-03 | |
| 2020-12-31 | $161.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $423.82M 10-K · filed 2022-03-01 |
| 2020-09-30 | $186.58M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $75.31M 10-Q · filed 2021-08-10 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.28M 10-K · filed 2022-03-01 |
| 2019-09-30 | $21.28M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |